{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:10:33Z","timestamp":1786990233098,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e30646","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T22:20:01Z","timestamp":1714774801000},"page":"e30646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-235X","authenticated-orcid":false,"given":"Zhixiao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7461-6569","authenticated-orcid":false,"given":"Zhongxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e30646_bib1","first-page":"7","article-title":"Cancer Statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.heliyon.2024.e30646_bib2","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2024.e30646_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted therapy and checkpoint immunotherapy in lung cancer","volume":"13","author":"Ruiz-Cordero","year":"2020","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.heliyon.2024.e30646_bib4","first-page":"479","article-title":"[Minimally invasive therapies for early stage non-small cell lung cancer]","volume":"23","author":"He","year":"2020","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.heliyon.2024.e30646_bib5","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.31557\/APJCP.2021.22.8.2501","article-title":"Lung cancer survival with current therapies and new targeted treatments: a comprehensive update from the srinagarind hospital-based cancer registry from (2013 to 2017)","volume":"22","author":"Musika","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.heliyon.2024.e30646_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/cgt.2016.40","article-title":"Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer","volume":"24","author":"Yan","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.heliyon.2024.e30646_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa060476","article-title":"Survival of patients with stage I lung cancer detected on CT screening","volume":"355","author":"Henschke","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e30646_bib8","article-title":"Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies","volume":"1877","author":"Chang","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.heliyon.2024.e30646_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168661","article-title":"Current and future development in lung cancer diagnosis","volume":"22","author":"Nooreldeen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e30646_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.48095\/ccko2021S6","article-title":"Lung cancer - dia nosis and early detection","volume":"34","author":"Skrickova","year":"2021","journal-title":"Klin. Onkol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib11","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cncr.29222","article-title":"Screening and early detection efforts in lung cancer","volume":"121","author":"Kanodra","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2024.e30646_bib12","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S1470-2045(14)70387-0","article-title":"Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers","volume":"15","author":"Horeweg","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/107327481402100102","article-title":"Lung cancer screening: advantages, controversies, and applications","volume":"21","author":"Nanavaty","year":"2014","journal-title":"Cancer Control"},{"key":"10.1016\/j.heliyon.2024.e30646_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12885-018-4024-3","article-title":"Serum and blood based biomarkers for lung cancer screening: a systematic review","volume":"18","author":"Chu","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e30646_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/EDBK_237863","article-title":"Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices","volume":"39","author":"Pennell","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.heliyon.2024.e30646_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.21873\/cgp.20128","article-title":"Diagnosis of non-small cell lung cancer for early stage asymptomatic patients","volume":"16","author":"Goebel","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.heliyon.2024.e30646_bib17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e30646_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nmeth.3485","article-title":"miRWalk2.0: a comprehensive atlas of microRNA-target interactions","volume":"12","author":"Dweep","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.heliyon.2024.e30646_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mam.2018.07.003","article-title":"MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance","volume":"70","author":"Iqbal","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.heliyon.2024.e30646_bib21","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.2174\/1381612823666170714151715","article-title":"MiRNA-based therapeutics for lung cancer","volume":"23","author":"Wu","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2024.e30646_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib23","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41419-022-05420-5","article-title":"Cancer-derived exosomal miR-197-3p confers angiogenesis via targeting TIMP2\/3 in lung adenocarcinoma metastasis","volume":"13","author":"Chang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e30646_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41374-021-00586-6","article-title":"LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p\/SOX5 axis in non-small-cell lung cancer","volume":"101","author":"Chen","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2024.e30646_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.heliyon.2024.e30646_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.trsl.2020.11.012","article-title":"miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer","volume":"230","author":"Zhong","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.heliyon.2024.e30646_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-319-23730-5_9","article-title":"microRNA and lung cancer","volume":"889","author":"Del Vescovo","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib28","first-page":"226","volume":"vol. 157","author":"Skrickova","year":"2018"},{"key":"10.1016\/j.heliyon.2024.e30646_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/JTO.0b013e3181dc213e","article-title":"Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan","volume":"5","author":"Kawaguchi","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib30","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e30646_bib31","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1073\/pnas.0809999106","article-title":"Serum-based microRNAs: are we blinded by potential?","volume":"106","author":"Jackson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e30646_bib32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/cr.2008.290","article-title":"A truth serum for cancer--microRNAs have major potential as cancer biomarkers","volume":"18","author":"Chin","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e30646_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1186\/s12885-019-5951-3","article-title":"microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e30646_bib34","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2019.190340","article-title":"Plasma MicroRNA-34a as a potential biomarker for early diagnosis of esophageal cancer","volume":"65","author":"Lin","year":"2019","journal-title":"Clin. Lab."},{"key":"10.1016\/j.heliyon.2024.e30646_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147588","article-title":"Molecular and circulating biomarkers of gastric cancer","volume":"23","author":"Jelski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e30646_bib36","doi-asserted-by":"crossref","first-page":"11434","DOI":"10.18632\/oncotarget.7196","article-title":"Examining plasma microRNA markers for colorectal cancer at different stages","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e30646_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/CBM-190256","article-title":"Circulating plasma microRNA signature for the diagnosis of cervical cancer","volume":"26","author":"Ma","year":"2019","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.heliyon.2024.e30646_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8024700","article-title":"MicroRNA-340 and MicroRNA-450b-5p: plasma biomarkers for detection of non-small-cell lung cancer","volume":"2022","author":"Wu","year":"2022","journal-title":"J Environ Public Health"},{"key":"10.1016\/j.heliyon.2024.e30646_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11548-015-1245-7","article-title":"Automated pulmonary nodule CT image characterization in lung cancer screening","volume":"11","author":"Reeves","year":"2016","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"10.1016\/j.heliyon.2024.e30646_bib40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/1759-7714.13982","article-title":"Liquid biopsies to distinguish malignant from benign pulmonary nodules","volume":"12","author":"Tao","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.heliyon.2024.e30646_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.21037\/atm.2019.03.59","article-title":"Diagnosis and management of peripheral lung nodule","volume":"7","author":"Khan","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e30646_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030415","article-title":"Circulating MicroRNA biomarkers for lung cancer detection in east asian populations","volume":"11","author":"Yu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e30646_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12943-017-0710-z","article-title":"MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6\/STAT3 and negatively correlates with poor prognosis","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e30646_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-017-0493-0","article-title":"MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK\/ERK signaling pathway","volume":"10","author":"Wei","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib45","doi-asserted-by":"crossref","first-page":"e989","DOI":"10.1002\/ctm2.989","article-title":"Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN\/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer","volume":"12","author":"Shi","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e30646_bib46","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in Cancer","volume":"16","author":"He","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e30646_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-022-01605-w","article-title":"MARCKSL1-2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b","volume":"21","author":"Jiang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e30646_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100933","article-title":"CPSF6-mediated XBP1 3'UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma","volume":"68","author":"Zhu","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.heliyon.2024.e30646_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.heliyon.2024.e30646_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of MicroRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e30646_bib51","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41374-022-00821-8","article-title":"Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2","volume":"102","author":"Shao","year":"2022","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2024.e30646_bib52","doi-asserted-by":"crossref","first-page":"71736","DOI":"10.18632\/oncotarget.17601","article-title":"UBE2J2 promotes hepatocellular carcinoma cell epithelial-mesenchymal transition and invasion in vitro","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e30646_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.200908036","article-title":"Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation substrates","volume":"187","author":"Wang","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2019.08.094","article-title":"ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways","volume":"518","author":"Xu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e30646_bib55","article-title":"A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells","volume":"10","author":"Chen","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2024.e30646_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-022-05067-4","article-title":"Post-translational control of beige fat biogenesis by PRDM16 stabilization","volume":"609","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e30646_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2019.05.005","article-title":"A PRDM16-driven metabolic signal from adipocytes regulates precursor cell fate","volume":"30","author":"Wang","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib58","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.heliyon.2024.e30646_bib59","first-page":"305","article-title":"Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA\/DNA interactions","volume":"40","author":"Sinkovics","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib60","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e30646_bib61","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nbt1394","article-title":"Discovering microRNAs from deep sequencing data using miRDeep","volume":"26","author":"Friedlander","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e30646_bib63","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/1073191113481054","article-title":"Miranda rights comprehension instruments: a critical review","volume":"20","author":"Frumkin","year":"2013","journal-title":"Assessment"},{"key":"10.1016\/j.heliyon.2024.e30646_bib64","doi-asserted-by":"crossref","first-page":"W451","DOI":"10.1093\/nar\/gkl243","article-title":"RNAhybrid: microRNA target prediction easy, fast and flexible","volume":"34","author":"Kruger","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e30646_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2024.e30646_bib66","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.7.10.986","article-title":"The significance of digital gene expression profiles","volume":"7","author":"Audic","year":"1997","journal-title":"Genome Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024066775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024066775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:09:33Z","timestamp":1775732973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024066775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024066775"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30646","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e30646"}}